BACKGROUND: Examining trends in cardiovascular events and mortality in US health systems can guide the design of targeted clinical and public health strategies to reduce cardiovascular events and mortality rates. METHODS AND RESULTS: We conducted an observational cohort study from 2005 to 2011 among 1.25 million diabetic subjects and 1.25 million nondiabetic subjects from 11 health systems that participate in the Surveillance, Prevention and Management of Diabetes Mellitus (SUPREME-DM) DataLink. Annual rates (per 1000 person-years) of myocardial infarction/acute coronary syndrome (International Classification of Diseases-Ninth Revision, 410.0–410.91, 411.1–411.8), stroke (International Classification of Diseases-Ninth Revision, 430–432.9, 433–434.9), heart failure (International Classification of Diseases-Ninth Revision, 428–428.9), and all-cause mortality were monitored by diabetes mellitus (DM) status, age, sex, race/ethnicity, and a prior cardiovascular history. We observed significant declines in cardiovascular events and mortality rates in subjects with and without DM. However, there was substantial variation by age, sex, race/ethnicity, and prior cardiovascular history. Mortality declined from 44.7 to 27.1 (P<0.0001) for those with DM and cardiovascular disease (CVD), from 11.2 to 10.9 (P=0.03) for those with DM only, and from 18.9 to 13.0 (P<0.0001) for those with CVD only. Yet, in the [almost equal to]85% of subjects with neither DM nor CVD, overall mortality (7.0 to 6.8; P=0.10) and stroke rates (1.6–1.6; P=0.77) did not decline and heart failure rates increased (0.9–1.15; P=0.0005). CONCLUSIONS: To sustain improvements in myocardial infarction, stroke, heart failure, and mortality, health systems that have successfully focused on care improvement in high-risk adults with DM or CVD must broaden their improvement strategies to target lower risk adults who have not yet developed DM or CVD.
BACKGROUND: Examining trends in cardiovascular events and mortality in US health systems can guide the design of targeted clinical and public health strategies to reduce cardiovascular events and mortality rates. METHODS AND RESULTS: We conducted an observational cohort study from 2005 to 2011 among 1.25 million diabetic subjects and 1.25 million nondiabetic subjects from 11 health systems that participate in the Surveillance, Prevention and Management of Diabetes Mellitus (SUPREME-DM) DataLink. Annual rates (per 1000 person-years) of myocardial infarction/acute coronary syndrome (International Classification of Diseases-Ninth Revision, 410.0–410.91, 411.1–411.8), stroke (International Classification of Diseases-Ninth Revision, 430–432.9, 433–434.9), heart failure (International Classification of Diseases-Ninth Revision, 428–428.9), and all-cause mortality were monitored by diabetes mellitus (DM) status, age, sex, race/ethnicity, and a prior cardiovascular history. We observed significant declines in cardiovascular events and mortality rates in subjects with and without DM. However, there was substantial variation by age, sex, race/ethnicity, and prior cardiovascular history. Mortality declined from 44.7 to 27.1 (P<0.0001) for those with DM and cardiovascular disease (CVD), from 11.2 to 10.9 (P=0.03) for those with DM only, and from 18.9 to 13.0 (P<0.0001) for those with CVD only. Yet, in the [almost equal to]85% of subjects with neither DM nor CVD, overall mortality (7.0 to 6.8; P=0.10) and stroke rates (1.6–1.6; P=0.77) did not decline and heart failure rates increased (0.9–1.15; P=0.0005). CONCLUSIONS: To sustain improvements in myocardial infarction, stroke, heart failure, and mortality, health systems that have successfully focused on care improvement in high-risk adults with DM or CVD must broaden their improvement strategies to target lower risk adults who have not yet developed DM or CVD.
Authors: Jane S Saczynski; Susan E Andrade; Leslie R Harrold; Jennifer Tjia; Sarah L Cutrona; Katherine S Dodd; Robert J Goldberg; Jerry H Gurwitz Journal: Pharmacoepidemiol Drug Saf Date: 2012-01 Impact factor: 2.890
Authors: Dharam J Kumbhani; Gregg C Fonarow; Christopher P Cannon; Adrian F Hernandez; Eric D Peterson; W Frank Peacock; Warren K Laskey; Prakash Deedwania; Maria Grau-Sepulveda; Lee H Schwamm; Deepak L Bhatt Journal: Am J Med Date: 2014-11-26 Impact factor: 4.965
Authors: Gregory A Nichols; Emily B Schroeder; Andrew J Karter; Edward W Gregg; Jay Desai; Jean M Lawrence; Patrick J O'Connor; Stanley Xu; Katherine M Newton; Marsha A Raebel; Ram D Pathak; Beth Waitzfelder; Jodi Segal; Jennifer Elston Lafata; Melissa G Butler; H Lester Kirchner; Abraham Thomas; John F Steiner Journal: Am J Epidemiol Date: 2014-12-16 Impact factor: 4.897
Authors: Lewis B Morgenstern; Melinda A Smith; Brisa N Sánchez; Devin L Brown; Darin B Zahuranec; Nelda Garcia; Kevin A Kerber; Lesli E Skolarus; William J Meurer; James F Burke; Eric E Adelman; Jonggyu Baek; Lynda D Lisabeth Journal: Ann Neurol Date: 2013-08-13 Impact factor: 10.422
Authors: Gregory A Nichols; Jay Desai; Jennifer Elston Lafata; Jean M Lawrence; Patrick J O'Connor; Ram D Pathak; Marsha A Raebel; Robert J Reid; Joseph V Selby; Barbara G Silverman; John F Steiner; W F Stewart; Suma Vupputuri; Beth Waitzfelder Journal: Prev Chronic Dis Date: 2012-06-07 Impact factor: 2.830
Authors: Sarah Stark Casagrande; Judith E Fradkin; Sharon H Saydah; Keith F Rust; Catherine C Cowie Journal: Diabetes Care Date: 2013-02-15 Impact factor: 19.112
Authors: JoAnn M Sperl-Hillen; A Lauren Crain; Karen L Margolis; Heidi L Ekstrom; Deepika Appana; Gerald Amundson; Rashmi Sharma; Jay R Desai; Patrick J O'Connor Journal: J Am Med Inform Assoc Date: 2018-09-01 Impact factor: 4.497
Authors: Todd Gilmer; Patrick J O'Connor; Jeffrey S Schiff; Gretchen Taylor; Gabriela Vazquez-Benitez; Joyce E Garrett; Houa Vue-Her; Sarah Rinn; Julie Anderson; Jay Desai Journal: Health Serv Res Date: 2018-05-16 Impact factor: 3.402
Authors: Abdulla A Damluji; Jin Huang; Karen Bandeen-Roche; Daniel E Forman; Gary Gerstenblith; Mauro Moscucci; Jon R Resar; Ravi Varadhan; Jeremy D Walston; Jodi B Segal Journal: J Am Heart Assoc Date: 2019-08-31 Impact factor: 5.501
Authors: Sudhi G Upadhyaya; Dennis H Murphree; Che G Ngufor; Alison M Knight; Daniel J Cronk; Robert R Cima; Timothy B Curry; Jyotishman Pathak; Rickey E Carter; Daryl J Kor Journal: Mayo Clin Proc Innov Qual Outcomes Date: 2017-04-28